Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Recs

0
Player Avatar Brian7992 (< 20) Submitted: 8/11/2009 2:29:09 PM : Outperform Start Price: $12.42 AGEN Score: -91.87

How Should I know!

Report this Post Reply

Featured Broker Partners


Advertisement